|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,310,000 |
Market
Cap: |
449.71(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.12 - $9.12 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Clayman Michael D. |
President and CEO |
|
2019-03-12 |
4 |
B |
$12.36 |
$50,009 |
D/D |
4,046 |
70,856 |
2.81 |
- |
|
Kelley Scott |
Chief Medical Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
51,271 |
|
- |
|
Arkowitz David |
Chief Financial Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
85,172 |
|
- |
|
Willwerth Christina |
Chief Strategy Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
58,419 |
|
- |
|
Wentworth Kerry |
Chief Regulatory Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
50,607 |
|
- |
|
Levine Mark S. |
General Counsel |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
45,060 |
|
- |
|
Bodick Neil |
Chief Scientific Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
100,782 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2019-01-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,936 |
319,002 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2019-01-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,936 |
69,932 |
|
- |
|
Levine Mark S. |
General Counsel |
|
2019-01-03 |
4 |
AS |
$12.36 |
$9,072 |
D/D |
(734) |
9,060 |
|
- |
|
Wentworth Kerry |
Chief Regulatory Officer |
|
2019-01-03 |
4 |
AS |
$12.36 |
$7,688 |
D/D |
(622) |
11,207 |
|
- |
|
Bodick Neil |
Chief Scientific Officer |
|
2019-01-03 |
4 |
AS |
$12.36 |
$9,221 |
D/D |
(746) |
64,782 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2019-01-03 |
4 |
AS |
$12.36 |
$40,516 |
D/D |
(3,278) |
66,810 |
|
- |
|
Kelley Scott |
Chief Medical Officer |
|
2019-01-03 |
4 |
AS |
$12.36 |
$7,688 |
D/D |
(622) |
15,271 |
|
- |
|
Arkowitz David |
Chief Financial Officer |
|
2018-12-20 |
4 |
A |
$10.48 |
$9,663 |
D/D |
922 |
49,172 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2018-11-09 |
4 |
B |
$17.10 |
$85,477 |
D/D |
5,000 |
69,166 |
2.81 |
- |
|
Arkowitz David |
Chief Financial Officer |
|
2018-11-09 |
4 |
B |
$16.56 |
$66,222 |
D/D |
4,000 |
48,250 |
2.74 |
- |
|
Clayman Michael D. |
President and CEO |
|
2018-10-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,567 |
314,066 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2018-10-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,567 |
64,166 |
|
- |
|
Wentworth Kerry |
Chief Regulatory Officer |
|
2018-10-08 |
4/A |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
14,876 |
|
- |
|
Bodick Neil |
Chief Scientific Officer |
|
2018-10-08 |
4 |
D |
$18.60 |
$25,017 |
D/D |
(1,345) |
65,528 |
|
- |
|
Bodick Neil |
Chief Scientific Officer |
|
2018-10-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,566 |
66,873 |
|
- |
|
Wentworth Kerry |
Chief Regulatory Officer |
|
2018-10-08 |
4 |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
11,476 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2018-10-08 |
4 |
D |
$18.60 |
$115,934 |
D/D |
(6,233) |
83,849 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2018-10-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,800 |
90,082 |
|
- |
|
249 Records found
|
|
Page 6 of 10 |
|
|